Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1

被引:9
|
作者
Koito, A [1 ]
Kameyama, Y
Cheng-Mayer, C
Matsushita, S
机构
[1] Kumamoto Univ, Ctr AIDS Res, Kumamoto 8600811, Japan
[2] Tokyo Univ Agr, Fac Bioind, Abashiri 0992493, Japan
[3] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
关键词
D O I
10.1128/JVI.77.9.5109-5117.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In vivo studies for understanding viral transmission and replication, host immune responses, and pathogenesis of human immunodeficiency virus type 1 (HIV-1) infection would greatly benefit from the establishment of a small-animal model. In this study, we explored the potential of American mink (Mustera vison) as a susceptible host. We found that primary cells and cell lines derived from this species efficiently supported trans-activation of the HIV-1 long terminal repeat by Tat. Accordingly, the cysteine residue at position 261, which has been shown to be important for interaction of the human cyclin T1 with the HIV-1 regulatory protein Tat, is conserved in the mink homologue. No species-specific defect in Rev function could be detected in mink cells. In addition, primary splenocytes, fibroblasts, and the Mv.1.Lu cell line from American mink supported early as well as late HIV-1 gene expression following infection with vesicular stomatitis G protein-pseudotyped HIV-1 viruses, at levels comparable to those seen with permissive human cells. Furthermore, the mink Mv.1.Lu cell line stably expressing human CD4 and CCR5 receptors supported a spreading HIV-1 infection with few, if any, deficiencies compared to findings in human cell lines. This indicates the potential of HIV-1 to replicate in these cells once the blockade at the stage of virus entry has been removed. These results clearly show that cells from American mink generally pose no functional intracellular block to HIV-1 replication, and collectively they raise the possibility that this animal species could be engineered to support HIV-1 infection, providing a useful small-animal model for evaluating de novo infection by HIV-1.
引用
收藏
页码:5109 / 5117
页数:9
相关论文
共 50 条
  • [31] ANTIVIRAL STRATEGIES IN THE REPLICATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    WAINBERG, MA
    BOUR, S
    GELEZIUNAS, R
    BENTWICH, Z
    UNION MEDICALE DU CANADA, 1992, 121 (05): : 307 - &
  • [32] Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions
    Ellerbrock, TV
    Lennox, JL
    Clancy, KA
    Schinazi, RF
    Wright, TC
    Pratt-Palmore, M
    Evans-Strickfaden, T
    Schnell, C
    Pai, R
    Conley, LJ
    Parrish-Kohler, EE
    Bush, TJ
    Tatti, K
    Hart, CE
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (01): : 28 - 36
  • [33] THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    MAKONKAWKEYOON, S
    LIMSONPOBRE, RNR
    MOREIRA, AL
    SCHAUF, V
    KAPLAN, G
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) : 5974 - 5978
  • [34] OLTIPRAZ, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    PROCHASKA, HJ
    YEH, Y
    BARON, P
    POLSKY, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 3953 - 3957
  • [35] Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA
    Mautino, MR
    Morgan, RA
    HUMAN GENE THERAPY, 2002, 13 (09) : 1027 - 1037
  • [36] Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures
    Asada, H
    Klaus-Kovtun, V
    Golding, H
    Katz, SI
    Blauvelt, A
    JOURNAL OF VIROLOGY, 1999, 73 (05) : 4019 - 4028
  • [37] Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells
    Mancino, G
    Placido, R
    Bach, S
    Mariani, F
    Montesano, C
    Ercoli, L
    Zembala, M
    Colizzi, V
    JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06): : 1531 - 1535
  • [38] Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication
    Srinivas, RV
    Ray, RB
    Meyer, K
    Ray, R
    VIRUS RESEARCH, 1996, 45 (02) : 87 - 92
  • [39] Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells
    Dezube, BJ
    Ahlers, CM
    Lawrence, JP
    Teng, EI
    Silberman, SL
    Pardee, AB
    Finberg, RW
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 14 (01) : 13 - 17
  • [40] Baseline susceptibility of primary human immunodeficiency virus type 1 to entry inhibitors
    Labrosse, B
    Labernardière, JL
    Dam, E
    Trouplin, V
    Skrabal, K
    Clavel, F
    Mammano, F
    JOURNAL OF VIROLOGY, 2003, 77 (02) : 1610 - 1613